Trial Profile
Carbetocin at Elective Cesarean Delivery: A Dose Finding Study (Part 1)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2018
Price :
$35
*
At a glance
- Drugs Carbetocin (Primary)
- Indications Postpartum haemorrhage
- Focus Therapeutic Use
- 12 Jun 2012 Primary endpoint 'Minimum-effective-dose' has not been met (unable to be calculated)
- 12 Jun 2012 Primary endpoint 'Uterine-measures' has been met.
- 09 Sep 2011 New trial record